These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16296698)

  • 1. 24-hour blood pressure control with the once-daily calcium antagonist amlodipine.
    Raftery EB; Heber ME; Brigden G; Al-Khawaja I
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S8-12. PubMed ID: 16296698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-arterial monitoring of the antihypertensive effects of once-daily amlodipine.
    Broadhurst P; Heber ME; Brigden G; al-Khawaja I; Raftery EB
    J Hum Hypertens; 1992 Dec; 6 Suppl 1():S9-12. PubMed ID: 1293307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of amlodipine on 24-hour ambulatory blood pressure in hypertensive patients.
    Mroczek WJ; Burris JF; Allenby KS
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S13-5. PubMed ID: 16296699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amlodipine in hypertension: its effects on platelet aggregation and dynamic exercise.
    Hernández R; Carvajal AR; Armas-de Hernande MJ; Guerrero-Pajuelo J; Armas-Padilla MC; Barragan O; Machado-de Alvarado I
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S25-7. PubMed ID: 16296703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dividing amlodipine daily doses on trough drug concentrations and blood pressure control over a 24-hour period.
    Miyoshi K; Okura T; Nagao T; Masanori J; Irita J; Higaki J
    Clin Ther; 2013 Sep; 35(9):1418-22. PubMed ID: 23972579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open evaluation of amlodipine in the monotherapeutic treatment of systolic hypertension in the elderly.
    Vandewoude MF; Lambert M; Vryens R
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S28-9. PubMed ID: 16296704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
    Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
    Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic and 24-h blood pressure profile of amlodipine monotherapy.
    Ibrahim MM; el-Boghdadly B; Zaghloul SS
    J Hum Hypertens; 1996 Jul; 10(7):489-94. PubMed ID: 8880565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind evaluation of the dose-response relationship of amlodipine in essential hypertension.
    Mehta JL; Lopez LM; Vlachakis ND; Gradman AH; Nash DT; O'Connell MT; Garland WT; Pickering BI
    Am Heart J; 1993 Jun; 125(6):1704-10. PubMed ID: 8498314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of amlodipine on ambulatory blood pressure in hypertensive patients.
    Burris JF; Allenby KS; Mroczek WJ
    Am J Cardiol; 1994 Jan; 73(3):39A-43A. PubMed ID: 8310975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of morning or evening dosing of amlodipine on circadian blood pressure and heart rate.
    Qiu YG; Chen JZ; Zhu JH; Yao XY
    Cardiovasc Drugs Ther; 2003 Jul; 17(4):335-41. PubMed ID: 14618095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antihypertensive efficacy of losartan and amlodipine assessed with office and ambulatory blood pressure monitoring. Canadian Cozaar Hyzaar Amlodipine Trial Study Group.
    Wilson TW; Lacourcière Y; Barnes CC
    CMAJ; 1998 Sep; 159(5):469-76. PubMed ID: 9757170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once-daily amlodipine in the treatment of mild to moderate hypertension.
    Webster J; Robb OJ; Jeffers TA; Scott AK; Petrie JC
    J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S72-5. PubMed ID: 2467134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once daily amlodipine in the treatment of mild to moderate hypertension.
    Webster J; Robb OJ; Jeffers TA; Scott AK; Petrie JC; Towler HM
    Br J Clin Pharmacol; 1987 Dec; 24(6):713-9. PubMed ID: 2964253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, placebo-controlled, double-blind comparison of amlodipine and atenolol in patients with essential hypertension.
    Johnson BF; Frishman WH; Brobyn R; Brown RD; Reeves RL; Wombolt DG
    Am J Hypertens; 1992 Oct; 5(10):727-32. PubMed ID: 1418836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.